Prof. Dr. Turgay Çelikel
OncologyVerified
- 47+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Cancer Surgery
Removal of nephroblastoma
What surgical removal of nephroblastoma (Wilms tumour) involves, including radical nephrectomy and nephron-sparing techniques, what clinical evidence shows about cure rates and protocols, approximate costs in Turkey compared with the UK, US, and Germany, the hospital timeline, recovery milestones, potential surgical risks, and how to choose an accredited paediatric oncology surgical centre.
A written plan with the surgeon's name and the full price — usually within 24 hours.
- Category
- Cancer Surgery
- Hospitals
- 2
- Verified
- 1
- Price from
- Price on request
Verified surgeons for Removal of Nephroblastoma
1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
What is removal of nephroblastoma and how is surgery planned?
Removal of nephroblastoma, or Wilms tumour surgery, is the surgical resection of a primary paediatric renal tumour. Nephroblastoma originates from immature kidney precursor cells and represents the vast majority of kidney cancers diagnosed in childhood, primarily affecting children between two and five years of age. The main surgical goal is the complete en bloc resection of the tumour and affected kidney with an intact capsule, alongside systematic retroperitoneal lymph node sampling. Preventing intraoperative tumour rupture is paramount, as spillage worsens the clinical stage and requires intensified therapy.
Surgery is integrated into a multimodal protocol alongside chemotherapy and, when indicated, radiation therapy. Depending on whether the European SIOP protocol or North American COG framework is followed, surgery occurs either after initial chemotherapy or upfront at diagnosis. This guide explains surgical techniques, international costs, recovery, and clinical risks. For broader cancer care pathways, explore our guide to oncology treatments in Turkey.
How does nephroblastoma surgery work step by step?
The operation is conducted under general anaesthesia with endotracheal intubation, supported by epidural or regional analgesia managed by paediatric anaesthetists for post-operative comfort. Prophylactic antibiotics and central vascular access, such as a port catheter, are routinely established.
The procedure follows structured surgical stages:
- Transperitoneal laparotomy: A generous transverse abdominal incision is made. Wide transperitoneal access is mandatory in paediatric oncology to inspect the liver, peritoneal cavity, and opposite kidney before mobilising the mass.
- Vascular isolation: The colon is mobilised medially to expose the retroperitoneum. The surgeon identifies the renal vein and vena cava to rule out tumour thrombus, ligating the renal vessels before significant tumour handling.
- En bloc resection: The kidney, surrounding perinephric fat, and tumour are mobilised intact. The ureter is divided low near the bladder. Gentle surgical technique prevents tearing the delicate tumour capsule.
- Lymph node sampling: Systematic regional lymph node sampling along the aorta and vena cava is compulsory for staging, comparable to node evaluation during removal of colon cancer.
- Closure: The surgical bed is checked for hemostasis, irrigated, and closed in layers with absorbable sutures. A wound drain is placed only if necessary.
The operation typically takes two to three hours, extending longer if vascular thrombus extraction is required.
Does removal of nephroblastoma work and what does evidence show?
Four decades of collaborative clinical trials confirm that surgical removal of nephroblastoma within multimodal protocols is highly effective. Data from the SIOP Renal Tumour Study Group and the Children's Oncology Group (COG) document overall five-year survival rates exceeding 85% to 90% for localized favourable-histology tumours.
Key evidence-based findings include:
- Complete resection enables cure: Complete tumour excision with clear margins and negative regional lymph nodes forms the primary basis for long-term remission in localized disease.
- Capsule integrity is critical: Tumour spillage during surgery upgrades the cancer to Stage III, requiring whole-abdominal radiotherapy and intensified chemotherapy. Preserving capsule integrity is a decisive surgical quality measure.
- Neoadjuvant chemotherapy reduces spillage: European SIOP trials demonstrate that pre-operative chemotherapy shrinks the tumour and hardens its pseudocapsule, reducing intraoperative rupture rates.
- Histological subtype guides prognosis: Diffuse anaplasia or blastemal predominance requires intensified chemotherapy, as surgery alone cannot overcome aggressive tumour biology.
Removal of nephroblastoma cost in Turkey compared with the UK, US and Germany
Financial estimates for paediatric surgical oncology reflect the resection, specialised paediatric anaesthesia, operating theatre resources, histopathology, and inpatient hospital care. The figures below provide approximate international price ranges rather than individual hospital quotes, as costs vary with surgical complexity and required hospital stay.
| Country | Approximate cost range |
|---|---|
| Turkey | €7,000 – €18,000 |
| United Kingdom | €16,000 – €35,000 |
| United States | €32,000 – €75,000 |
| Germany | €15,000 – €32,000 |
The overall removal of nephroblastoma price is influenced by tumour dimensions, paediatric intensive care unit (PICU) monitoring, pre-operative cross-sectional imaging, and central line insertion for subsequent chemotherapy. For removal of nephroblastoma Turkey hospital packages typically encompass surgeon and anaesthetist fees, private room accommodation for the child and one parent, pre-operative testing, routine medications, pathology staging, and transfers. Families can obtain an upfront written review through our free quote page.
Radical nephrectomy, partial resection or delayed surgery: which technique is used?
The surgical technique depends on tumour laterality, kidney function, and protocol design. Unlike adult tissue-conserving surgeries such as lumpectomy, paediatric renal tumour surgery must achieve complete oncological margins while considering lifelong renal capacity.
| Surgical approach | Best suited to | Typical limits |
|---|---|---|
| Complete radical nephrectomy | Unilateral tumours with normal contralateral kidney; standard approach in initial resection. | Results in single kidney; requires strict avoidance of capsule breach. |
| Nephron-sparing surgery (partial) | Bilateral Wilms tumours, solitary kidney, or predisposing syndromes (e.g. Beckwith-Wiedemann). | Risk of positive margins; limited to polar or peripheral tumours. |
| Delayed post-chemotherapy surgery | Large, fragile tumours, cavoatrial thrombus, or standard SIOP protocols. | Alters initial tumour histology; requires scheduled pre-operative cycles. |
For over 90% of children with unilateral disease, total radical nephrectomy remains standard. Nephron-sparing resections are reserved for bilateral involvement or genetic syndromes requiring maximal nephron preservation.
Which children are candidates for nephroblastoma removal?
A dedicated paediatric oncology tumour board evaluates each child's surgical candidacy, balancing clinical staging, imaging, and anaesthetic safety.
General criteria for proceeding with surgery include:
- Resectable localized tumour: Tumours anatomically confined to the kidney and retroperitoneal tissues without fixed encasement of major mesenteric vasculature.
- Anaesthetic stability: Adequate cardiorespiratory fitness confirmed through paediatric pre-operative assessments.
- Haematological recovery: Children undergoing surgery after chemotherapy must demonstrate adequate neutrophil and platelet counts prior to theatre.
Surgery is temporarily postponed if massive tumours present high rupture risks that pre-operative chemotherapy can reduce, or if an extensive cavoatrial thrombus requires multidisciplinary planning with paediatric cardiac surgeons.
What do post-operative imaging and pathology results show?
Following resection, the kidney and lymph nodes undergo comprehensive histopathological analysis. Pathologists verify surgical margins, vascular and capsular invasion, and lymph node status, classifying the tumour by histology (favourable, blastemal, or anaplastic) to confirm pathological staging from Stage I to V.
Post-operative imaging, including abdominal ultrasound, CT, or MRI, confirms an empty tumour bed and evaluates the contralateral kidney's adaptation. Routine chest imaging screens for lung clearance. Rather than cosmetic before-and-after photographs, oncology progress is measured through clear scans, stable renal blood panels, and steady paediatric development milestones.
Parents receive detailed pathology documentation outlining tumour necrosis percentages if pre-operative chemotherapy was administered, which dictates whether subsequent treatment can be de-escalated or requires intensification.
Travel to Turkey, hospital stay and recovery timeline
When arranging removal of nephroblastoma in Turkey, international families typically plan for a 14 to 21-day stay. This covers pre-operative re-staging, hospital admission, and post-operative surgical reviews before commercial flight clearance.
The recovery journey follows key milestones:
- Inpatient admission (Days 1–5): The child spends the initial night in the paediatric intensive care unit (PICU) or high-dependency unit for vitals and pain control before moving to a private paediatric ward room with a parent.
- Bowel recovery and mobility (Days 2–4): Clear liquids advance to regular meals as bowel function returns. Gentle walking is encouraged, and surgical drains are removed once drainage settles.
- Discharge (Days 5–7): Discharge occurs once the child eats comfortably, manages with oral painkillers, and demonstrates healthy single-kidney urine output.
- Flight clearance (Days 10–14): The surgeon inspects wound healing, reviews histology, and provides a "fit to fly" certificate.
During removal of nephroblastoma recovery, the clinical team coordinates with the home oncologist to ensure seamless continuation of therapy.
Surgical risks, capsule rupture prevention and complications
Paediatric nephrectomy is a major surgical procedure. Guidelines from the British Association of Paediatric Surgeons (BAPS) and the Children's Oncology Group identify the following clinical risks and prevention strategies:
- Tumour rupture (capsule spill): Rupturing the fragile tumour capsule disperses malignant cells into the peritoneal cavity, upgrading disease to Stage III and necessitating radiotherapy. Surgeons prevent this through wide exposure and gentle handling.
- Haemorrhage: Fragile renal vessels distorted by tumour bulk risk significant bleeding. Paediatric surgical teams maintain early vascular control and cross-match blood products beforehand.
- Adjacent organ trauma: Adherent tumours may place the spleen, pancreas, colon, or diaphragm at risk during dissection, requiring meticulous surgical planes.
- Post-operative ileus or obstruction: Temporary bowel slowdown is common and managed supportively. Long-term adhesional bowel obstruction occurs in a small percentage of abdominal procedures.
- Renal function: The remaining healthy kidney undergoes compensatory enlargement to support normal filtration. Long-term blood pressure and urine checks are recommended.
How to choose a paediatric oncology centre and red flags to watch for
Nephroblastoma surgery should only be performed in tertiary hospitals equipped with specialised paediatric surgery, on-site paediatric intensive care units (PICU), and dedicated paediatric oncology teams rather than general adult departments.
Parents evaluating international centres should ask prospective clinics:
- Is the surgeon a board-certified paediatric surgeon experienced in paediatric oncological resections?
- Is there an accredited on-site Paediatric Intensive Care Unit (PICU) available 24/7?
- Does a multidisciplinary tumour board review the diagnostic scans and histopathology?
- Does the facility follow established international protocols, such as SIOP or COG?
- What clear documentation and coordination are provided for our home oncologist?
Red flags include facilities lacking dedicated paediatric intensive care, quotes provided without reviewing CT or MRI scans, surgeons proposing narrow flank incisions that compromise oncological exposure, and guarantees of cure. Learn how it works when coordinating care abroad, or request verified hospital details through our free quote service.
Conditions treated with Removal of Nephroblastoma
Hospitals with Oncology in Turkey
Frequently asked questions
Removal of nephroblastoma, or Wilms tumour surgery, is the surgical excision of a malignant paediatric kidney tumour. The operation involves en bloc removal of the affected kidney and intact tumour capsule, accompanied by systematic regional lymph node sampling. It forms a key part of multimodal cancer treatment alongside chemotherapy.
Yes. When performed as part of established multimodal oncology protocols (such as SIOP or COG), surgical removal is highly curative. Five-year overall survival rates for localized favourable-histology nephroblastoma exceed 85% to 90%, provided the tumour capsule remains intact during surgery and stage-appropriate chemotherapy is administered.
Approximate costs in Turkey typically range between €7,000 and €18,000, compared with €16,000 to €35,000 in the UK and higher in the US. The total price depends on paediatric intensive care duration, surgical complexity, pathology staging, and whether a chemotherapy port is placed simultaneously.
Radical nephrectomy removes the entire kidney, surrounding fat, and tumour en bloc, and is the standard approach for unilateral disease. Partial (nephron-sparing) nephrectomy preserves healthy renal tissue and is reserved for children with bilateral tumours, a solitary kidney, or genetic conditions predisposing them to future contralateral tumours.
Intraoperative rupture or capsule spillage is a serious complication because it scatters malignant cells across the abdomen. This upstages the cancer to Stage III, requiring whole-abdominal radiotherapy and escalated chemotherapy. Experienced paediatric surgical oncologists use wide transperitoneal incisions and avoid direct tumour grasping to prevent capsule tearing.
Most children stay in hospital for five to seven days, beginning with 24 hours of close monitoring in paediatric intensive care. Bowel function and gentle walking usually resume within two to four days. Full physical recovery takes three to six weeks, during which outpatient chemotherapy is typically initiated.
Yes. The remaining solitary kidney undergoes compensatory hypertrophy, growing larger to handle the full filtering demands of the body. Most children lead active, normal lives with excellent kidney function. Long-term medical care involves annual blood pressure checks, urine protein screening, and avoiding contact sports that risk solitary kidney trauma.
The surgical team prevents intraoperative pain with general anaesthesia combined with continuous epidural or regional nerve blocks. Post-operatively, intravenous analgesics are closely managed by paediatric specialists. Discomfort peaks in the first 48 hours and gradually decreases, transitioning to mild oral painkillers before discharge from hospital.
Yes, in virtually all clinical protocols. Nephroblastoma is exceptionally responsive to chemotherapy. Depending on whether European or North American guidelines are followed, chemotherapy is given either before surgery to shrink the tumour or after surgery to eliminate micro-metastases. The duration and specific drug regimen depend on post-operative pathological staging.
Families should plan for an international stay of 14 to 21 days. This allows sufficient time for pre-operative imaging reviews, surgical admission of five to seven days, initial histopathology evaluation, and post-discharge recovery before the paediatric surgeon issues a formal fit-to-fly certificate.
Patient stories